ROS1 (6q22) gene break apart rearrangement detection probe CE-IVD
Catalog No : FP-006
513.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | ROS1 (6q22) gene break apart rearrangement detection probe CE-IVD | ||
|---|---|---|---|
| Catalog No | FP-006 | ||
| Supplier’s Catalog No | FP-006 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | ROS1 | ||
| Reactivity | ROS1, diagnosis of drug (XALKORI: Crizotinib) sensitivity | ||
| Cross reactivity | None | ||
| Applications | Fluorescence In Situ Hybridization (FISH) for diagnosis of human Lymphomas | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Professional In Vitro diagnostics | ||
| Description | ROS1 gene break-apart rearrangement occurs mostly in young, non-smoking lung adenocarcinoma patients. ROS1 rearrangements are different from other mutations such as EGFR, KRAS and ALK. The positive rate of ROS1 rearrangement is about 1.5%, and ROS1 rearrangement positive adenocarcinoma is poorly differentiated. ROS1 break-apart rearrangement positive patients are sensitive to XALKORI (Crizotinib) drugs. | ||
Product Details
© 2020 Imugex All Rights Reserved